财新传媒
财新英文 > 要闻 > 正文

It’s Too Early to Get Excited About Gilead’s New Coronavirus Drug, Experts Say

2020年02月07日 20:33 来源于 分分快三代理-分分快三
Although remdesivir so far appears to be more effective at fighting the deadly virus than other antivirals, the evidence remains light
Experts say Gilead’s drug remdesivir looks promising, but that it’s far too early to get excited. Photo: IC Photo

Shares in American biotech company Gilead Sciences Inc. climbed to a more than six-month high this week on news that it had been given the green light to start human trials of an experimental antiviral drug on coronavirus patients in China.

版面编辑:喻竹杨洋
财新私房课
好课推荐